Nrf2 coordinately activates these genes and exerts a protective function against xenobiotic and oxidative stresses ( Figure 1
Efficacy and Safety of Semaglutide Compared With Liraglutide and Placebo for Weight Loss in Patients With Obesity: A Randomised, Double-Blind, Placebo and Active Controlled, Dose-Ranging, Phase 2 Trial
Parkinsons: Drug Could Stall Worsening Symptoms Participants in a phase II trial with Parkinsons who took an older GLP-1 called lixisenatide saw no worsening of motor function symptoms over a year, compared to the placebo group who did see intensified symptoms
The future of targeted gene-based treatment strategies and biomarkers in Parkinsons disease
We don't just want to provide you with supplements
The subcutaneous route exists for researchers using a lyophilized vial format, but it is limited to small doses